SmartWard successfully completes trial of their hospital ward management system

SmartWard announced that it has completed the trial of its innovative new system for hospital ward management.  Researchers from Deakin University’s Centre for Quality and Patient Safety Research and RMIT’s Health Innovations Research Institute are currently analysing the results, which should be available by the end of November.  Pending their formal report, we are pleased to advise that informal feedback is that:

• The trial has demonstrated SmartWard is effective and reliable on a real ward managing real patients,
• Nurses in a live clinical setting like SmartWard and find it easy to use,
• Incidents of missed care were reduced
• SmartWard creates a far more accurate and comprehensive record of care,
• Participating nurses said that it saved them time and enabled them to deliver better care

In addition, SmartWard demonstrated flexibility and adaptability to changing hospital clinical needs when the team was able to respond to 57 separate requests for additions or changes to the system made during Stages 1 and 2 of the trial.  The changes were all implemented while Stages 1 and 2 were completed and rolled out for Stage 3.  Stage 3 proceeded with zero defects.

This adaptability is a key competitive advantage for SmartWard and is based on a proprietary system for generating software code based on business rules.  Changes to most hospital IT systems are both time-consuming and expensive, which is a key complaint from hospitals about current vendors.

With the completion of the clinical trial, SmartWard has initiated commercial discussions with a number of hospitals.

SmartWard automates nursing records and manages nursing workflow, while improving the quality of care.  Software coupled with smart sensors helps nurses to schedule and record activities much faster than conventional means, while creating a record of care of unprecedented accuracy and depth. SmartWard thus refocuses nursing care on patients.

SmartWard is currently undertaking a capital raising.  The target is $3 million, of which over $2.5 million has already been secured.